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Introduction
That after an acute massive hemorrhage there is a marked
reduction in the perfusion of the body organs is well known.
Indeed, there is a marked generalized vasoconstriction with an
increase in the total vascular resistance. Dogs experimentally
hemorrhaged to an arterial pressure of 35 mm. Hg . show a doubling
in their total vascular resistance (12) . No organ is spared,
perfusion declining to all the vital tissues (12,28,36). This
vasoconstriction and decreased perfusion is well reflected after
hemorrhage in a decrease in total oxygen consumption in the dog
(17,35). Thus according to Guyton and Crowell a vicious circle
is established, in which hemorrhage leads to decreased oxygen
transport. This leads to decreased oxygen available to the tissues,
which leads to an oxygen debt, which leads finally through several
"unknown intermediate steps" to cardiac failure, as evidenced by
a decrease in cardiac output even after an increase in venous pressure.
This decreased cardiac output leads to decreased oxygen transport
and the vicious circle is closed (17) . Thus these investigators
feel that the primary cause of death in irreversible hemorrhagic
shock is heart failure (3,4,5). This concept is shared by many other
investigators (1,40,42,43).
So perhaps if the above mentioned vicious cycle is interrupted
somewhere, namely at the point of cardiac failure, through the use
of digitalis, "irreversible hemorrhagic shock" could be reversed.
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The digitalis drugs have been found to cause peripheral
vasoconstriction (2) . Ross and Braunwald (32) gave 46 dogs
digitalis, the cardiac action of digitalis being excluded by
the use of a cardiopulmonary bypass. They found that "at a
constant perfusion rate a significant elevation of arterial
pressure occurred in each instance." This they state reflected
an augmentation of the peripheral vascular resistance. Further
more, the elevation of the arterial pressure was not abolished
by ganglionic blockage or by adrenalectomy. Arterial splanchnic
ligation also failed to change the elevation of arterial pressure.
A pressor response limited to the constantly perfused lower aorta
was recorded when acetylstrophanthidin was injected into this
vascular portion. When the injection was made into the upper
segment of the animals, a reflex fall in pressure was observed
in the lower segment. Thus they concluded that digitalis acts
directly on the arteriolar smooth muscle to induce an increase in
peripheral vascular resistance.
Interestingly, one other large effect of digitalis on the
peripheral circulation is that of a pooling of blood in the
splanchnic bed. Dock and Tainter (7) found that in dogs, tincture
of digitalis in therapeutic doses caused an increase in the size
of the liver and the spleen due to hepatic vein constriction and
to a pooling of blood in these viscera. They further observed that
there was a decrease in right atrial pressure, a simultaneous
increase in portal vein pressure, and a decrease of blood returning
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to the heart (37) . If however, the liver was eliminated by
shunting the portal blood into the inferior vena cava, or if
the arteries supplying the splanchnic area were ligated, they found
that digitalis did not cause a fall of venous pressure, but in
several instances raised it. Others have observed similar effects
of digitalis on the splanchnic bed (23), with Nadler, et al (29)
noting that the action of ouabain is much shorter on the splanchnic
vessels than on the heart.
Experiments by Ross and Braunwald (33) on healthy dogs,
utilizing a preparation in which the cardiac effects were excluded,
showed that there was a decline in venous return, with a consequent
intravascular pooling of blood averaging 12.7 ml. /kg. body weight.
Conversely in dogs in which pooling in the splanchnic bed was
prevented, an increase in venous return a decline in intravascular
volume averaging 7.6 ml. /kg. body weight was noted.
With these vasoconstrictive properties of digitalis in mind,
let us turn briefly to the effects of vasoconstrictor agents in
hemorrhagic shock.
At the present time the deleterious or at least non-beneficial
effects of vasoconstrictors in hemorrhagic shock is accepted by
many (10,24,30,35). Indeed, even in healthy dogs severe vasoconstric
tion is harmful, as evidenced by the fact that unhemorrhaged dogs,
given injections of adrenalin (13) , or infusions of norepinephrine
(44) in high enough doses, will develop shock.
Remington, e_t al_ (31) showed that dogs hemorrhaged while receiving
an epinephrine infusion showed a shorter survivial period at low pressure
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and flow levels than controls.
Drucker, et al (24), in a very interesting experiment,
hemorrhaged two groups of dogs and maintained them at an arterial
pressure of 50 mm. Hg . for 90 minutes. During the next 60 minutes
group A was given enough norepinephrine to raise the mean arterial
pressure to 100 mm. Hg . , while the other, group B, was hemorrhaged
further and was maintained at 30 mm. Hg. without drugs. Then all
the dogs were transfused rapidly with all their shed blood. The
norepinephrine infusion was not continued after transfusion. In
group A all dogs died between 5 minutes to 6 hours after transfusion.
In group B deaths occurred between 1 to 12 hours. Also, after
transfusion, group A showed a rise in pyruvic and lactic acid levels
(indicating anaerobic metabolism), as opposed to a fall in these
levels back to prehemorrhage values in group B. These results
suggest that after prolonged hypovolemia, the use vasoconstrictor
agents may actually increase the metabolic defects they were hoped
to correct.
Conversely, vasodilator agents may be beneficial in hemorrhagic
shock (30,35). However, pretreatment with vasodilators in controlled
hemorrhagic shock may only be reflecting a smaller bleeding volume
to attain the same degree of hypotension as in control animals (24,39).
Therefore, the experimental group actually has a larger circulating
blood volume than the control. Thus, Remington, et_ al_ (31) found
that if vasoconstriction after hemorrhage was largely prevented by
15 mg./kg. of dibenamine, the lethal blood volume of the dog was
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greatly decreased, but the animal could survive pressure and flow
levels which were fatal to the control. Interestingly however,
a smaller dose of dibenamine (5mg./kg.) allowed a normal bleeding
volume and still protected the animal's life. They stated that
the mechanism of this protective action was obscure.
Johnson, et_ al (22) found that isoproterenol, a cardiac and
beta-receptor stimulating drug, was much less effective in terms
of increased blood flow than a relatively poor volume expander
such as isotonic saline, although under hypotensive conditions
of oxygen deficit, isoproterenol seemed to improve oxygen trans
port and use.
Still other investigators (41) have found that the use of
vasodilator agents in hemorrhagic shock is deleterious.
The exact role of vasodilator agents in hemorrhagic shock
awaits further clarification. The data on vasopressor agents,
however, seems to indicate that they are detrimental in hemorrhagic
shock.
Returning now to digitalis, we see that as early as 1926
Harrison and Leonard (18) claimed that digitalis is contraindicated
in hemorrhagic shock because in this condition there is no visceral
or peripheral congestion, i.e. venous return to the heart is decreased.
Glaser and Page (14) bled two groups of dogs and maintained
them at an arterial pressure of 50 mm. Hg. for 90 minutes. Then
the dogs were bled to 30 mm. Hg. for 45 minutes. At this point
the dogs were reinfused, the experimental animals receiving ouabain
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either during the reinfusion or shortly thereafter. They found
that the experimental group's survival was not helped by the use
of digitalis.
Because of the evidence suggesting that myocardial failure
was responsible for irreversible shock, McPherson and Haller (26)
performed a study on hemorrhagic shock in 35 dogs. A control
groups was bled using the reservoir technique. They were allowed
to deteriorate into irreversible hemorrhagic shock. (Irreversibility
was defined as that point at which dogs began to take up blood
from the reservoir which was maintained at a pressure of 30 mm. Hg.)
The experimental group was given the cardiac glycoside, ouabain,
either prior to hemorrhage, during hemorrhage, or after irreversi
bility had been established. Their results showed that the maximum
amount of hemorrhage, time of onset of irreversibility, atrial
pressures, portal vein pressures, pulmonary artery pressures, pH,
and hematocrit were not significantly different in the two groups.
Also, no significant or consistent changes were noted in the atrial
pressures at the time of irreversibility. Ouabain did not correct,
prevent, or significantly alter irreversible hemorrhagic shock in
the dog. They concluded that there was no justification for the use
of digitalis preparations as preventive measures against irreversible
shock.
In contrast to the above findings, Crowell and Smith (6) found
that the use of digitalis is indeed beneficial in hemorrhagic shock.
They showed that the important factor in hemorrhagic shock was the
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oxygen deficit an animal accumulated and not the length of time
required to reach this deficit. Thus, all hemorrhaged dogs
reaching an oxygen deficit of 100 ml. /kg. body weight lived if
promptly reinfused. If reinfusion was delayed until 120 ml. /kg.
of oxygen deficit was attained, 507o of the dogs eventually died
as a consequence of the hemorrhage. At 140 ml. /kg. oxygen debt,
all the dogs eventually died. However, if hemorrhaged dogs
were digitalized with ouabain upon restoration of their normal
blood volume, all dogs withstood an oxygen deficit of 140 ml. /kg.
and half survived an oxygen deficit of 165 ml. /kg. An oxygen
debt of 200 ml. /kg. was fatal to all digitalized dogs.
Unal, e_t al_ (38) found in experiments on dogs that digitali-
zation of hypovolemic dogs caused a significant rise in pH and
a more nearly normal pH after reinfusion than the pH values in
control animals. Lactic and pyruvic acid levels which rose three
to five fold and persisted at this level in controls declined
after ouabain. Ouabain during hypovolemia also lowered the lactate-
pyruvate ratio, primarily due to a greater diminution in lactic
acid than in pyruvic acid. Thus their experiments showed that
digitalization prevents some of the anaerobic metabolic changes
observed in hemorrhagic shock, thereby showing that digitalis
may be helpful in the treatment of hemorrhagic shock.
With the presented information concerning the peripheral
vasoconstrictive effects of digitalis, the deleterious effects
of vasoconstrictor agents in hemorrhagic shock, and our knowledge
of the well known positive inotropic effect of digitalis on the
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heart, we find that it would be difficult to predict whether
digitalization would be beneficial in hemorrhagic shock. The
positive inotropic effect we might predict would be beneficial,
whereas the vasoconstrictive effects would be detrimental. How
these two effects would interact is confusing, as are we find,
the conflicting reports on the usefulness of digitalis in hemor
rhagic shock. Therefore, it was decided to study the effects of
digitalis in hemorrhagic shock. More specifically, the present
study will concern itself with the effects of digitalis on oxygen
consumption and cardiac output in hemorrhagic shock.
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Materials and Methods
Seventeen mongrel dogs weighing between 10.7 and 24.1 kgs .
were anesthetized with 0.6 cc./kg. Dial-urethane (Ciba) intra
venously. The neck and the left thigh region were shaved. The
trachea was intubated with a rubber tracheal cannula with an
inflatable balloon cuff to insure air tightness. This cannula
was connected to an Oxford Instrument Company Continuous Oxygen
Consumption Analyzer. This instrument was set to provide an
airflow (room air) of 4 liters/min., the oxygen consumption being
determined by the difference in oxygen concentration of the inflow-
outflow air.
The left femoral vein was exposed and cannulated using a
#7 polyvinyl cannula (1.9 cc . volume), fitted with a threeway
stopcock and filled with isotonic saline. The cannula tip was
passed to the inferior vena cava, to the level of the diaphragm.
Through this cannula the dogs were heparinized using 3.7 mg./kg.
of Liquaemin sodium 10 (Organon) . This cannula was also used for
injection of drugs: ouabain and vasoxyl, and also for injection
of room temperature saline for cardiac output determinations.
The left femoral artery was exposed and cannulated using a
polyvinyl cannula with a thermistor (Veco, type 32A11, Victory
Engineering Corp., Union, N.J.) at its tip. This cannula was
passed to the descending aorta, at the level of the diaphragm.
It was filled with heparinized isotonic saline and was fitted with
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a threeway stopcock, which was connected to a Statham P23Db pressure
transducer, connected to an Electronics for Medicine, Inc. Electron
Oscillograph. In this manner blood pressure could be continuously
monitored through the experiments. Heart rate/min. was obtained
by counting peaks in the blood pressure tracing over a 12 second
period and multiplying by five. The transducer and the oscillo
graph were calibrated both at the beginning and at the end of each
experiment against a mercury manometer, in every experiment no
difference being noted between these separate calibrations. The
signal from the thermistor was amplified and was also recorded by
the oscillograph.
The left common carotid artery was exposed and cannulated
using a polyvinyl cannula inserted approximately 5 cm. into the
artery. This cannula was fitted with a threeway stopcock, one
opening being connected to a pressurized inverted 1000 ml. glass
bottle containing 3 ml. (30 mg.) of heparin and used for collecting
the hemorrhaged blood. The other opening of the stopcock was
fitted with a 50 cc. glass syringe for finer control of hemorrhage
volume .
A thermometer (Arthur H. Thomas Co., -20 to +107 degrees
centigrade calibrated in one degrees) was inserted into the rectum
to measure the dog's temperature. A similar thermometer was placed
into a glass beaker containing 200 cc. of room temperature saline
heparinized with 10 mg . of heparin. This solution was used as the
injectate for cardiac output determinations.
Cardiac output determinations were done as follows: After
withdrawing 5 cc . of blood to warm the cannula, anywhere from 3 cc .
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to 8 cc . of isotonic saline was injected via the left femoral
cannula into the inferior vena cava. Change in temperature of
the blood-saline bolus was detected by means of the heat
sensitive thermistor in the aorta and recorded by the oscillo
graph. A typical curve was of the form:
nr\nr\,
: i ty\t
' *
The area under this curve was calculated by using a planimeter
(Keuffel and Esser Co., No. 4236M) to measure the area, A ,
o
under the curve to the left of P-. . This area in mm. was
converted to mm. -sec. by dividing by the paper speed (mm. /sec.).
The area, A„ } under the curve to the right of P was calculated
by observing that this is an exponential decay function.
Employing calculus and integrating between t and infinity it
was seen that A„ = P » At/logP - logP , where P.. is the distance
from the baseline in mm., At is the time between P., and P1 2
(in sec), and P is the distance from the baseline. The total
area under the curve was then ( in mm. -sec.) the sum of A and
A„ . The cardiac output was from Goodyer, et al (15):
60HD ( V-AT - K)b s
Hb VS t
in ml . /min.
where: H is the thermal capacity of saline (1.00 cal ./gm. -degree)
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H, is the thermal capacity of blood (0.87 cal. /gm. -degree) , D,
is thedensityof blood (1.045 gm./ml.), D is the density of
saline (1.005 gm./ml.), V is the volume of the injectate in ml.,
<&T is the temperature change of the injectate in degrees centigrade^
K is the heat exchange with the catheter (9.0 ml. -degrees for the
catheter used), A is the area of the thermal curve in mm. -seconds,
and St is the change of temperature of blood per mm. of galvono-
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meter deflection (25 x 10 for the thermistor used) .
This method of cardiac output determination is very satis
factory for estimating the cardiac output of intact animals, and
has the advantage of no blood having to be permanently withdrawn.
Also, it has no dosage limitations (11) . These determinations
correlate very closely with values obtained by the Fick procedure (16) .
The original 5 cc. of blood withdrawn to warm the cannula
before each saline injection was in each case returned to the
animal promptly after a thermal dilution curve was obtained.
This was done to prevent a moderate loss of blood volume by the
cumulative effect of small withdrawals.
Oxygen deficit was used to estimate the progression of
shock (6, 17). The cumulative oxygen debt levels were calculated
by adding the minute-to-minute differences between the resting
prehemorrhage level of oxygen consumption and the lower hypotensive
level of oxygen consumption, and dividing this cumulative total
by the dog's weight. The point at which the blood pressure
first reached 35mm. Hg. was used as the beginning of oxygen debt.
The protocol was as follows: 5 dogs were hemorrhaged to
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an arterial pressure of 35 mm. Hg . until an oxygen deficit of
approximately 75 ml. /kg. was attained. At this point, in every
case between 70 and 80 ml. /kg. of oxygen deficit, 0.02 mg./kg. of
ouabain (Lilly), which is close to the therapeutic dose (2 9), was
injected intravenously. From this point on no attempt was made
to control blood pressure. Throughout the experiments, before
hemorrhage, and at varying intervals, blood pressure, heart
rate, and cardiac output were recorded. Oxygen consumption was
monitored constantly.
Two dogs were done in exactly the same manner, except
instead of injecting ouabain, an equal volume of isotonic saline
(one to two cc.) was injected at the appropriate time.
The other 10 experiments were done similarly except that
the blood pressure was held constant at 35 mm. Hg. during the
entire experiment, necessitating adjustment of blood volume
throughout each experiment. In four of the ten experiments
ouabain, 0.02 mg./kg., was injected. In two experiments saline
(approximately 1 to 2 cc.) was injected. In two experiments,
vasoxyl, 1 mg./kg., (Burroughs Wellcome & Co. (U.S.A.) Inc.)
was injected. This falls within the dosage range recommended by
Innes and Nickerson (20). In two experiments, an isuprel
(Winthrop Laboratories) infusion, necessitating an extra cannula
in the right femoral vein and a Harvard Apparatus Co., Inc. Dual
Infusion/Withdrawl Pump, Model 600-910, was used. The dosage of
isuprel was 3.82 ug./min. which is above the dose recommended by
MacLean (25) , but is less than the amount used by Hawthorne (19) .
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The infusion period was between an oxygen deficit of 75 ml . /kg . and
175 ml. /kg. The volume infused was 0.382 cc./min. It was felt
that this extra volume was negligible and would not affect the
experimental results.
Calculations :
Resting values for oxygen consumption, cardiac output, blood
pressure, and heart rate for each dog in all experiments were the
average of two prehemorrhage observations, adequate time being
allowed after the surgical procedure for each dog to stabilize.
After hemorrhage each experiment was divided into four
intervals: baseline, interval A, interval B, and interval C.
Baseline was defined as the interval between 40 and 70 ml. /kg. of
oxygen debt, interval A as the interval between 100 and 150 ml. /kg.
of oxygen debt, interval B as the interval between 150 and 200 ml. /kg.
of oxygen debt, and interval C as the interval between 200 and 250 ml. /kg.
of oxygen debt. In each respective interval there were usually two
observations each for cardiac output, heart rate, and blood pressure.
These two observations were averaged for each interval. Rarely
only one observation was made in an interval and in this event
the one value was used (See Tables I through XVII) .
As oxygen consumption was monitored continuously through each
experiment, the value for the oxygen consumption in each respective
interval was the time weighted average between the specified
oxygen debt levels .
The blood volume removed was variable because of the constant
need to hemorrhage or infuse blood while maintaining a stable
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blood pressure of 35 mm. Hg.
Results
Tables I through V and table A summarize the results
obtained in four dogs hemorrhaged to 35 mm. Hg . and then given
ouabain at an oxygen debt level of approximately 75 ml. /kg.,
the blood pressure thereafter not being controlled. It is apparent
that after hemorrhage, the oxygen consumption, the cardiac output,
and the blood pressure decrease markedly in each case, with the
heart rate varying, increasing in some and decreasing in others.
With the injection of ouabain, there is an increase above the
preinjection baseline value in oxygen consumption, cardiac out
put, blood pressure, and heart rate. The oxygen consumption
increased from between 8.37, to 777., average 477o, in the oxygen
debt levels between 100 and 150 ml. /kg., interval A. Thereafter,
in interval B, between 150 and 200 ml. /kg. oxygen debt, the
oxygen consumption is 347> above the baseline value. Between
200 and 250 ml. /kg. oxygen debt, interval C, it is 357, above the
baseline value.
The cardiac output also increased. However this was not
observed in every animal, in fact 2 animals showed a slight
decrease .
With two similar experiments using a saline injection instead
of ouabain, it was found as seen in Tables VI, VII, and B, that
here too there was a large increase in oxygen consumption and
cardiac output. The increase above the baseline value here was
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in fact slightly greater than that observed in the ouabain
experiments, 547, vs. 477, in oxygen consumption and 777, vs. 307,
in cardiac output in interval A.
The hemorrhage volume in the dogs given ouabain averaged
47.5 ml. /kg. Those receiving isotonic saline showed a hemorrhage
volume of 60.3 ml. /kg. The hemorrhage being performed entirely
prior to drug injection indicates only individual variation.
It is apparent that any effect the ouabain may be having
is obscured by the fact that the dog is apparently spontaneously
compensating for his hemorrhage. Because of this tremendous
tendency for spontaneous recovery after a hemorrhage when the
blood pressure is not controlled, it was decided to change the
protocol slightly and hold the blood pressure constant through
out the ensuing experiments. The results from these appear in
Tables VIII through XVII and Tables C through F.
Tables VIII through XI and Table C summarize the results
obtained in four dogs hemorrhaged to an arterial pressure of
35 mm. Hg., with ouabain being injected very near 75 ml. /kg. of
oxygen debt, and blood pressure being held constant. It is
apparent that in each case there was a drop in oxygen consumption
and cardiac output below baseline values in all the intervals A,
B, and C in each experiment. The average decrease in oxygen
consumption in these respective intervals was, -387,, -407,, and
-407,. The average decrease in cardiac output was -407,, -317,, and
-237, respectively.
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On comparing these results with 2 dogs receiving isotonic
saline instead of ouabain, Tables XII, XIII, and D, it is seen
that these two dogs showed slight variation, i.e. one dog showed
an increase in oxygen consumption and cardiac output above base
line values, and one dog showed a slight decrease in these values.
However, the average values for these two dogs were slightly above
baseline values, +5.97,, +9.57,, and +1.07, at intervals A,B, and C
for oxygen consumption, and +5.07,, +7.07, and +117, for cardiac out
put, respectively.
The heart rate in these two types of experiments varied so
greatly from one dog to another that no clear trend was observed.
The estimated hemorrhage volume too showed variation, how
ever, the trend observed in dogs receiving ouabain was one of
initial blood withdrawal after the ouabain injection, followed
by slow reinfusion later as the dogs deteriorated. In one saline
experiment blood had to be withdrawn throughout the experiment,
while in the other, blood had to be reinfused much earlier than
in any one of the ouabain experiments .
Tables XIV, XV, and E summarize the results obtained in 2
dogs injected with vasoxyl. Here it is apparent that the oxygen
consumption decreased below baseline levels in both cases, the
average change at intervals A, B, and C being -157=,, -5.07,, and
-4.67, respectively. On comparing this to the similar ouabain
experiments, we see that the oxygen consumption is in the same
direction in both experiments, however the magnitude of change
is greater in the ouabain experiments .
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The cardiac output too decreased initially, -147, in interval
A, but then is seen to rise, +177, in interval B, only to fall
again, -5.57, in interval C. Except for this transient increase
in cardiac output in interval B, the trend for the cardiac out
put is to decrease below the baseline value, at least initially,
as was the case in the ouabain experiments .
The heart rate in the two vasoxyl experiments showed a tendency
to increase above the baseline values.
The estimated hemorrhage volume at first increased after the
vasoxyl injection, but then decreased during the course of the
experiments as the dogs deteriorated.
Tables XVI, XVII, and F summarize the results obtained in 2
dogs receiving an isuprel infusion. Here it is seen that the 2
dogs varied somewhat, one showing an increase in oxygen consumption
above the baseline value, the other showing a slight decrease, the
average being +6.47,, +3.57,, and -5.07, at intervals A, B, and C
respectively. These findings are similar to the saline injection
experiments .
Of interest here is that the cardiac output on the otherhand
decreased below the baseline levels, the average being -6.77,, -207,,
and -347, at intervals A, B, and C respectively. Thus despite a
decreased output, the oxygen consumption increased.
Apparent from this data too is that the heart rate increased
dramatically with the infusion of isuprel.
One dog had to be continuously hemorrhaged to maintain a constant
blood pressure, whereas the other dog needgino adjustment in blood
-19-
volume to maintain a constant blood pressure.
The important results in summary are that dogs hemorrhaged
to a blood pressure of 35 mm. Hg., with no attempt being made to
control the blood pressure thereafter, will spontaneously show
an increase in oxygen consumption and cardiac output above base
line levels of a degree which is comparable to the increases
seen in these values if these dogs are treated with ouabain.
Dogs which on the otherhand were hemorrhaged to a blood pressure
of 35 mm. Hg., were given ouabain, and had their blood pressure
maintained at this level, showed a marked decrease in oxygen con
sumption. Thus, they accumulated an oxygen debt more rapidly
than the dogs treated with saline or the vasodilator, isuprel. The
dogs receiving saline or isuprel in fact showed a slight decrease
in the rate at which an oxygen debt accumulated (an increase in
oxygen consumption). Dogs treated with the vasopressor, vasoxyl,
reacted in a manner similar to those receiving ouabain, i.e. their
oxygen consumption decreased.
(The numbers of the animals in each group are too small to
lend themselves to statistical analyses).
-20-
Legend
Tables I through XVII summarize the results of individual
dogs. Resting values are prehemorrhage values. Thereafter,
values are from hypovolemic dogs. Baseline is defined as the
interval between an oxygen debt of 40 and 70 ml. /kg., Interval
A as the interval between an oxygen debt of 100 and 150 ml. /kg.,
Interval B as the interval between 150 and 200 ml. /kg. of oxygen
debt, and Interval C as the interval between 200 and 250 ml . /kg .
of oxygen debt. Values for cardiac output, heart rate, and
blood pressure are average values between the specified oxygen
debt levels. Usually these were an average of two observations.
Rarely there was only one observation for cardiac output, heart
rate, and blood pressure. In this event, the value for the one
observation was used. The values for oxygen consumption are
the time weighted averages between the specified oxygen debt
levels. Oxygen debt is in ml. /kg. Oxygen consumption is in
ml./min.-kg. Cardiac output is in ml./min.-kg. Blood pressure
is in mm. Hg . Heart rate is rate/minute. Time is in minutes.
Tables A through F summarize average percent changes from
baseline values. Oxygen debt is ml. /kg.
-21-
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Table IX
Dog: 18.4 kg. male Type: Ouabain, b.p. controlled
Ouabain at 22.0 rain, at Op debt of 77.6 ml/kg
Resting Baseline Interval A Interval B Interaal
Oxygen debt 0 40 - 70 100 - 150 150 - 200 200 - 250
Oxygen cons .
% change from
baseline
7.0 3.7 2.4
-35
1.6
-57
1.3
-65
Oardiac output
■■/<> change from
baseline
126 13.5 10.3
-24
6.4
-53
13.3
-1.5
Blood pressure 153 35 35 35 35
Heart rate 130 170 135 45 60
Hemorrhage vol. 54 60 53 53
Time 0 10.7--19.7 27.5-3'3.3 "38.3-47..5 47,5-56.3
Table X
Dop-: 18.0 kr. male Type: Ouabain, b.p. controlled
Ouabain at 16.0 rain, at Op debt of 75.8 ml/kg
Resting Baseline Interval A Interval B Interval G
Oxygen debt 0 40 - 70 100 - lc50 150 - 200 200 - 241
Oxygen cons. 7.2 2.7 1.9 2.1 died @> 241
Jo change from
baseline -30 -22
Cardiac output 156 12.4 8.5 8.9 10.5
P change from
baseline -31 -28 -15
Blood pressure 195 35 35 35 35
Heart rate 193 145 145 145 155
Hemorrhage vol. 47 51 49 49
Time 0 8.0-14.7 20.9-30,.3 30.3-40..5 40.5-50.0
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Table XI
Dog: 24.1 kg. male Type: Ouabain, b.p. controlled
Ouabain at 21.0 min. at Op debt of 77-3 ml/kg
Resting Baseline Interval A Interval B Interval
Oxygen debt
Oxygen cons .
:% change from
baseline
Cardiac output
3 change from
baseline
Blood pressure
Heart rate
Hemorrhage vol.
Time
Table XII
Dog: 10.7 kg. male Type: Saline, b.p. controlled
Saline at 13.0 min. at 0o debt of 71.3 ml/kg
Resting Baseline Interval A Interval B Interval 0
0 40 - 70 100 - 150 15 7 - 2;JO 200 - 250
6.0 2.3 1.3
-44
1.5
-35
2.2
-4.4
117 21.8 11.2
-49
19.4
-11
16.2
-26
150 35 35 35 35
132 120
41
80
46
120
46
120
37
0 10.9-■19.0 26.0-36,.7 36.7-47 Q 47.3-60.8
Oxygen debt 0 40 - 70 100 - T:>0 150 - 200 200 - 250
Oxygen cons.
■i change from
baseline
10.5 5.4 6.2
+15
6.4
+19
6.2
+15
Cardiac output
fo change from
baseline
276 26.6 35.9
+35
34.9
+31
34.6
+30
Blood pressure 155 35 35 35 35
He. rt rate 170 135 140 145 150
Hemorrhage vol. 49 56 61 63
Time 0 6.8-12.7 19.5-31,.2 31.2-4-3,.3 43.3-54.9
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Table a I II
Dog: 21.4 kg. male Type: Saline, b.p. controlled
Saline at 23.0 min. at Op debt of 72.0 ml/kg
Oxygen debt
Resting
0
Basel
40 -
.ine
70
Interval A
100 - 150
Interval B
150 - 200
Interval C
200 - 250
Oxygen cons.
"/o change from
baseline
6.0 3.0 2.9
-3.3
3.0
0
2.6
-13
Cardiac output
% change from
baseline
77.4 11.3 3.8
-25
Q ;3
-17
11.0
-7.3
Blood pressure 178 35 35 35 35
Heart rate 130 220 175 150 93
Hemorrhage vol. 44 40 39 35
Time 0 12.5-•22.4 32.4-48.5 48.5-65.1 65.1-30.0
?able XIV
Dog: 17.0 kg. male Type: Vasoxyl, b.p. controlled
Vasoxyl at 19.0 min. at Op debt of 76.3 ml/kg
Resting Baseline Interval A Interval B Interval C
Oxygen debt 0 40 - 70 100 - 150 150 - 200 200 - 250
Oxygen cons .
■fo change from
baseline
7.3 3.7 3.3
-11
3.5
-5.4
3.7
0
Cardiac output
f change from
baseline
157 140 11.4
-19
14.5
+3.6
10.9
-22
Blood pressure 170 33 35 35 35
Heart rate 158 133 133 170 180
Hemorrhage vol. 53 66 66 63
T ime 0 10.1-■17 = 5 25.9-35..0 35.0-46,.7 46.7-58.6
Table XV
Dor: 21.6 kg. female Type: Vasoxyl, b.p. controlled
Vasoxyl at 20.0 min. at Op debt of 75.6 ml/kg
Oxygen debt
Resting
0
Basel
40 -
.ine
70
Interval A
100 - 150
Interval B
150 - 20 0
Interval C
200 - 253
Oxygen cons.
fo change from
baseline
5.9 2.2 1.0
-IS
2.1
-4.5
2.0
-9.1
Cardiac output
fo change from
baseline
127 12.2 11.0
-9.3
16.0
+31
13.5
+11
Blood pressure 140 35 35 35 35
Heart rate 118 105 123 158 175
Hemorrhage vol. 53 55 54 54
Time 0 10.5-■18.6 25.3-37.4 37.4-50.4 50.4-63.1
Table XVI
Dog: 16.6 kg. male Type: Isuprel infusion, b.p. controlled
Start isuprel infusion at 13.0 min. at Op debt of 77.3 ml/kg
Stop isuprel infusion at 33.0 min. at 00 debt of 176.0 ml/kg2
Resting Baseline Interval A Interval B Inteival C
Oxygen debt 0 40 - 70 100 - lc.>0 150 - 200 200 - 250
Oxygen cons.
f> change from
baseline
9.6 3.9 4.5
+15
4.7
+21
4.4
+13
Cardiac output
fo change from
baseline
82.4 17.4 16.1
-7:5
16.1
-7.5
11.7
-33
Blood pressure 155 35 35 35 35
Heart rate 90 130 175 200 173
Hemorrhage vol. 39 48 50 51
Time 0 6.4-11.7 17.8-27,.6 27.6-37.8 37.8-47.4
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Table XVII
Dog: 13.9 kg. female Type: Isuprel infusion, b.p. controlled
Start isuprel infusion at 29.0 min. at Op debt of 78.2 ml/kg
Stop isuprel infusion at 72.0 rain, at Op debt of 175.0 ml/kg
Resting Baseline Interval A
Oxygen debt 0 40 - 70 100 - 150
Oxygen cons. 6.6 4.4 4.3
f change from
baseline -2.3
Cardiac output 85.4 16.8 15.8
fo change from
baseline -5.9
Blood pressure 155 35 35
Heart rate 110 110 210
Hemorrhage vol. 36 48.5
Time 0 12.2-25.6 40.4-62.0
Interval a Interval 0
150 - 200 200 - 250
3.8 3.4
-14 -23
11.3 11.1
-33 -34
35 35
188 155
48.5 48.5
62.0-79.7 ,'9.7-95.3
-30-
Table A
Average fo change from baseline values for ouabain expts. with
blood pressure not controlled. 5 dogs
Interval A Interval B Interval C
Oxygen debt 100 - 150 150 - 200 200 - 250
Average 3 change Op cons. +47 +34 +35*
Av. % change cardiac output +30 +26 +22
Table B
Average f chnage prom baseline values for saline expts. with
blood pressure not controlled. 2 dogs
Interval A Interval B Interval C
Oxygen debt 100 - 150 150 - 200 200 - 250
Av. fo change 0? cons. +54 +38 +29
av. fo change cardiac output +77 +101 +106
Table 0
Average / change from baseline values for ouabain expts. with
blood pressure controlled. 4 dogs
Interval A Interval B Interval C
)-X•-*
Oxygen debt 100 - 150 150 - 200 200 - 250
Av. f change 0? cons. -38 -40 -401
Av. f> change cardiac output -40 -31 -23
* 4 dogs
x* 3 dogs
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Table D
Average f change from baseline values for saline expts. with
blood pressure controlled. 2 dogs
Interval A Interval B Interval C
Oxygen debt 100 - 150 150 - 200 200 - 250
Av. fo change 0? cons. +5.9 +9.5 +1.0
Av. fo change cardiac output +5.0 +7.0 +11.4
Table jj
Average fo change from baseline values for vasoxyl expts. with
blood pressure controlled. 2 dogs
Interval A Interval B Interval C
Oxygen debt 100 - 150 150 - 200 200 - 250
Av. fo change Op cons. -15 -5.0 -4.6
Av. fo change cardiac output -14 +17 -5.5
Table F
Average $> change from baseline values for isuprel expts. with
blood pressure controlled. 2 dogs
Interval A Interval B Interval C
Oxygen debt 100 - 150 150 - 200 200 - 250
Av. f change Op cons. +6.4 +3.5 -5.0
Av. f change cardiac output -6.7 -20 ■ -34
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Discussion
Crowell and Smith (6) have stated that lowering the arterial
pressure to some given value does not produce a consistent degree
of hypoxia from one animal to another- This is borne out in the
experiments presented here, for the time required to reach a
specific oxygen debt varied from one animal to another -
It has been shown that the oxygen debt level gives a very
good quantitative means of measuring the degree of shock (6,17,34),
the LD for untreated dogs being 120 ml. /kg. of oxygen debt, where
as dogs treated with digitalis after reinfusion show an LD at
50
165 ml. /kg. of oxygen debt. It is further stated that the rate
at which an oxygen debt accumulates is immaterial, for as long as
the critical oxygen debt is attained, irreversibility will be
encountered. The present study cannot varify or disprove these
statements, as no attempt was made to study survival in these
experiments .
It seems reasonable, however, that the rate at which an oxygen
debt is accumulating may be important in terms of valuable time
gained while treating patients in hemorrhagic shock, for the
longer the time required to reach irreversibility, the more time
there is to get valuable blood to the patient.
The experiments in this study, in which after hemorrhage and
ouabain injection no attempt is made to control blood pressure,
do not answer the question whether oxygen debt rate is changed
due to ouabain. The increase in oxygen consumption (decrease in
-33-
oxygen debt rate) seen with ouabain was of the same magnitude as
that observed in dogs given saline. Perhaps if the number of
animals in the control group had been larger, the results would
have been different. All that can be said is that ouabain did
not seem to improve the animal's condition in terms of blood
pressure, cardiac output, and the very important oxygen debt rate,
to any greater extent than that observed if the dog is allowed to
recover spontaneously. Thus digitalis here seemed to have no
greater effect than an equal volume of saline.
The experiments in which blood pressure was maintained at a
constant pressure are not therapeutic in the sense that one would
make every effort to stop hemorrhage in a patient in hemorrhagic
shock, as opposed to withdrawing blood as was done here.
Ouabain injection caused a marked decrease in cardiac out
put and oxygen consumption. A similar effect was noted with vasoxyl,
an exclusively alpha-receptor stimulating drug with no significant
effect on the heart (20) . (Vasoxyl is known to cause a decrease
in blood flow in the peripheral blood vessel by causing vasoconstric
tion (27) .) It seems then that the major effect of ouabain in these
experiments is peripheral vasoconstriction, for its effects in these
experiments are similar to those observed for vasoxyl.
Further impetus is given for the latter statement if we examine
the results obtained with isuprel and compare these to the results
obtained with ouabain.
Isuprel, a beta-receptor stimulator, lowers peripheral vascular
resistance and also has positive inotropic and chronotropic effects
-34-
on the heart (20,25). Thus, isuprel' s action on the heart is
similar to ouabain's but its peripheral action is opposite
to the vasoconstrictive effects of ouabain.
In these experiments isuprel caused a decrease in cardiac
output, yet in the face of this, the oxygen consumption increased
slightly. This is probably due to peripheral vasodilation allowing
adequate perfusion of the tissue (even with a lowered cardiac out
put) to maintain a slightly elevated oxygen consumption. Now
if ouabain had caused peripheral vasodilatation, a similar result
would have been expected. However, ouabain injection caused a
decrease in oxygen consumption. Therefore, the explanation of
the observed differences in the oxygen consumption in these two
experiments lie most probably in the peripheral vasoconstrictive
effects of ouabain. Seemingly ouabain's positive inotropic effects
are not at play.
That the effects observed with the three drugs used are real,
is varified by the saline control experiments, which uniquely
showed a slight rise in both cardiac output and oxygen consumption.
These increases are on the basis of spontaneous recovery and have
been observed by others (35) .
It would be tempting to relate the oxygen consumption in
these experiments simply to the volume of blood remaining in the
animal, i.e. with greater vasoconstriction due to a pressor agent
injection, more blood is expected to be removed to maintain the same
blood pressure. Thus, a smaller circulating volume would remain for
-35-
oxygen transport and the oxygen consumption would be expected to
fall. It was found in all the controlled blood pressure experi
ments that blood was withdrawn after drug injection regardless
of whether a vasopressor or a vasodilator agent was injected, with
no trend being noted between experiments as to the quantity
removed. This is probably more artifactual than real, for the
hemorrhage volumes are most assuredly inaccurate. It was tech
nically extremely difficult if not almost impossible to make
correct measurements of hemorrhage volume while blood was con
stantly being withdrawn and reinfused and while other measurements
were taken. Thus the hemorrhage volumes here are nothing more
than rough estimates .
Thus, although the results cannot be explained to be due to
differences in circulating blood volume, they are meaningful.
Remembering the literature cited concerning the deleterious effects
of vasoconstrictor agents in hemorrhagic shock, and with the results
here presented that ouabain acts mainly as a peripheral vasoconstrictor
in hemorrhagic shock, it seems reasonable to conclude that digitalis
during hypovolemia is detrimental. Indeed, there is no good reason
to believe that digitalis would be helpful in a state of hypovolemia,
for its positive inotropic effects on the heart is mainly seen when
there is a rise in atrial filling pressure. In hypovolemia atrial
pressure is low. It would appear then, that the only value of digitalis
in hemorrhagic shock would be to support the myocardium during rapid
blood replacement.
-36-
Summary
Five mongrel dogs were hemorrhaged to an arterial pressure
of 35 mm. Hg . The blood pressure was allowed to fluctuate after
ouabain injection. It was found that after drug injection this
group was not different from a control group of two dogs, in
terms of rise in cardiac output and oxygen consumption.
Ten mongrel dogs were hemorrhaged to an arterial pressure of
35 mm. Hg., with maintenance of this pressure throughout the
experiments. Ouabain, vasoxyl, isuprel, and saline were given
at the appropriate times. It was found that under these conditions,
ouabain acted similarly to the vasopressor, vasoxyl, in terms of
decreasing both cardiac output and oxygen consumption. The
implication of this similarity is discussed in light of the
accepted detrimental effects of vasopressors in hemorrhagic shock.
-37-
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